Drug search by name

Trospium Extended-Release Capsules and Renal impairment

Result of checking the interaction of drug Trospium Extended-Release Capsules and disease Renal impairment for safety when used together.

Check result:

Trospium Extended-Release Capsules <> Renal impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Trospium is known to be substantially excreted by the kidney, and the risk of adverse reactions may be greater in patients with impaired renal function. The use of trospium is not recommended in patients with severe renal impairment (creatinine clearance less than 30 mL/minute). Caution is recommended when using this agent in patients with creatinine clearance ranging from 30 to 80 mL/min as the pharmacokinetics of trospium have not been studied in patients.

Trospium Extended-Release Capsules

Generic Name: trospium

Brand Name: Sanctura, Sanctura XR, Regurin

Synonyms: Trospium

What is Trospium Extended-Release Capsules?